← Open Payments lookup

WILLIAM SIMPSON: Open Payments

NPI 1144879628 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,067 in 40 payments from 20 companies in 2025. Trend: 2023 $1,639 · 2024 $1,313 · 2025 $1,067

Food & beverage: $1,062Education: $5
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.4$207
ConvaTec Inc.4$99
PFIZER INC.4$84
Ferring Pharmaceuticals Inc.3$70
Olympus America Inc.3$66
AstraZeneca Pharmaceuticals LP2$63
Dendreon Pharmaceuticals LLC2$59
Myriad Genetic Laboratories, Inc.3$59
Merck Sharp & Dohme LLC2$50
Janssen Biotech, Inc.2$46

Products named: GEMTESA, XTANDI, GENTLECATH GLIDE, ADSTILADRIN, iTIND System, LYNPARZA, PROVENGE, PROLARIS.

Industry payments across OR — which companies pay providers there.